News roundup
Netherlands to run trials of marijuana in patients with multiple sclerosis
Tony Sheldon Utrecht
The Dutch government has announced a small scale cross over trial into the effect of three sorts of medical marijuana, plus a placebo, on 16 patients with multiple sclerosis.
Two foundations in Rotterdam, the Institute for Medical Marijuana and Maripharm, have been contracted by the government to produce the drug to a standard quality and provide metal pipes for inhalation.
A Bureau for Medical Cannabis, set up by the ministry and the Amsterdam’s Free University medical centre, will run the year’s trial.
The bureau also intends to make medicinal cannabis available through pharmacists on prescription by spring 2003. The Dutch cabinet recently agreed to change the law to permit this.
Four trials of cannabis are taking place in the United Kingdom. The cannabis in multiple sclerosis (CAMS) study, which is sponsored by the Medical Research Council, started at Derriford Hospital, Plymouth, last year and
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
StumbleUpon 
Technorati What's this?
Rapid Responses:
Read all Rapid Responses
- Government agency for cannabis
- Willem K. Scholten
bmj.com, 11 Mar 2002 [Full text]
This Article
- Abridged text
- Abridged PDF
- Full text
- Respond to this article
- Read responses to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Related Content
-
Clinical trials (epidemiology)
-
Drug issues
-
Immunology (including allergy)
-
Multiple sclerosis
-
Pain (neurology)
- Find this article in its weekly table of contents
Bookmark with
What's new
Latest blogs
Find BMJ on:
Services
Tools
Online poll
Resources
Print issues
